Novartis | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 327.88B 42.76B 2025-06
Alcon AG CHF 34.72B 6.87B 2025-06
Almirall EUR 2.29B 195.31M 2025-06
Amgen USD 150.13B 17.37B 2025-06
AstraZeneca GBP 215.51B 41B 2025-06
Autolus Therapeutics Ltd 606.8M 194.3M 2025-06
Bayer EUR 25.09B 3.38B 2025-06
Biogen USD 18.41B 1.62B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Eli Lilly USD 738.79B 2.87B 2025-06
Fresenius EUR 24.04B 1.84B 2025-06
Fresenius Medical Care EUR 14.27B 870.85M 2025-06
Galapagos EUR 1.57B 31.54M 2025-06
Genmab DKK 80.88B 7.82B 2025-06
Gilead Sciences USD 137.91B 1.77B 2025-06
GlaxoSmithKline GBP 56.24B 4.11B 2025-06
GRIFOLS EUR 6.33B 1.14B 2025-06
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
J&J USD 366.71B 32.94B 2025-06
Merck EUR 47.83B 7.27B 2025-06
Merck USD 198.77B 27.1B 2025-06
Novartis CHF 256.18B 64.49B 2025-06
Novartis USD 258.67B 24.42B 2025-09
Novo Nordisk A/S 1.96T 370.19B 2025-06
Orion EUR 8.99B 1.28B 2025-06
Pfizer USD 137.53B 6.19B 2025-06
Philips EUR 19.65B 2.33B 2025-06
Recordati EUR 10.98B 42.75M 2025-06
Regeneron Pharmaceuticals USD 55.87B 13.47B 2025-06
Sanofi EUR 100.06B 25.78B 2025-06


Novartis Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.